國務院:將擴大集中採購和使用藥品品種範圍
國務院總理李克強主持召開國務院常務會議,部署深化醫藥衛生體制改革進一步推進藥品集中採購和使用,並通過《中華人民共和國城市維護建設稅法(草案)》。
會議提到,要求擴大集中採購和使用藥品品種範圍,優先將原研藥與仿製藥價差較大的品種,及通過仿製藥質量和療效一致性評價的基本藥物等納入集中採購,以帶量採購促進藥價實質性降低。確保集中採購藥品穩定供應和質量安全,建設藥品追溯系統,明年底前率先實現疫苗和國家集中採購使用藥品「一物一碼」,並可由公眾自主查驗。
此外,要推動醫療機構首先使用國家基本藥物和醫保目錄藥品,加強醫院藥事管理,並建立健全藥品價格常態化監管機制。同時,原則上對同一通用名相同劑型和規格的原研藥、通過一致性評價的仿製藥等實行相同的支付標準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.